- You can view the full Biogen Idec Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The trial enrolled 1,313 RMS patients in 21 countries for two years of study.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.